AKEBIA THERAPEUTICS, INC. Current Liabilities
AKEBIA THERAPEUTICS, INC. (AKBA) had Current Liabilities of $160.87 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $160.87M.
- 2026-03-31: Liabilities, Current $173.88M.
- 2025-12-31: Liabilities, Current $162.94M.
- 2025-09-30: Liabilities, Current $133.38M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $160.87M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $173.88M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $162.94M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $133.38M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $118.72M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $91.23M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $80.91M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $65.71M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $107.30M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $66.49M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $99.87M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $79.70M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $92.18M 10-Q · filed 2023-08-28 | |
| 2023-03-31 | $87.66M 10-Q · filed 2023-08-28 | $82.94M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $129.54M 10-K · filed 2024-03-14 | $124.76M 10-K · filed 2023-03-10 |
| 2022-09-30 | $193.13M 10-K/A · filed 2023-08-28 | $187.97M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $237.40M 10-K/A · filed 2023-08-28 | $233.68M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $258.50M 10-K/A · filed 2023-08-28 | $253.91M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $261.05M 10-K/A · filed 2023-08-28 | $256.49M 10-K · filed 2022-03-01 |
| 2021-09-30 | $189.21M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $165.59M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $172.68M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $187.15M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $181.46M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $195.77M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $214.15M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $208.12M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $223.15M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $185.62M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $202.61M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $265.69M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $177.40M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $164.42M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $151.42M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $141.11M 10-K · filed 2019-03-26 | $144.35M 10-K · filed 2018-03-12 |
| 2017-09-30 | $151.36M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $181.59M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $133.46M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $114.27M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $26.14M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $20.93M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $13.41M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $11.87M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $14.17M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.90M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $8.84M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.88M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $6.52M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $4.77M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $6.12M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.90M 10-K · filed 2015-03-04 | $3.90M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |